Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
Bioorganic & Medicinal Chemistry|October 31, 2006
Vascular disrupting agentsJohn W Lippert
Anti-Cancer Drug Design|October 26, 2000
Antineoplastic agents 429. Syntheses of the combretastatin A-1 and combretastatin B-1 prodrugsG R Pettit, J W Lippert
The Journal of Clinical Investigation|September 1, 1974
Pulmonary alveolar macrophage. Defender against bacterial infection of the lungE Goldstein, W Lippert, D Warshauer
The Journal of Infectious Diseases|December 1, 1978
Effect of protein A on the antistaphylococcal defence mechanisms of the murine lungS Hsieh, E Goldstein, W Lippert, et al.
The American Review of Respiratory Disease|September 1, 1977
Neonatal lung defense mechanisms: a study of the alveolar macrophage system in neonatal rabbitsM Sherman, E Goldstein, W Lippert, et al.
Pediatric Research|March 1, 1982
Group B streptococcal lung infection in neonatal rabbitsM Sherman, E Goldstein, W Lippert, et al.
Archives of Environmental Health|November 1, 1979
Effect of near ambient exposures to sulfur dioxide and ferrous sulfate particles on murine pulmonary defense mechanismsE Goldstein, D Y Chang, W Lippert, et al.
The Journal of Organic Chemistry|November 15, 2000
A pinacol rearrangement/oxidation synthetic route to hydroxyphenstatinG R Pettit, J W Lippert, D L Herald
The American Review of Respiratory Disease|February 1, 1977
Effect of influenza viral infection on the ingestion and killing of bacteria by alveolar macrophagesD Warshauer, E Goldstein, T Akers, et al.
Pageof 4